Prem baby's death closes Toronto neonatal unit

NewsGuard 100/100 Score

A neonatal intensive care unit in a Toronto hospital has been forced to close following the death of a premature baby there from a bacteria deadly to premature infants.

The tiny baby which was born two weeks ago died from serratia in the unit at Mount Sinai Hospital.

Dr. Allison McGeer, director of infection control says the infant died of bacteremia, commonly known as blood poisoning after acquiring serratia, a harmful pathogen that causes severe infections in babies.

The baby's death has triggered concerns and prompted special infection control procedures, including improved hand hygiene and the wearing of gowns and gloves in the neonatal intensive care unit which cares for some of the sickest, most fragile babies in Toronto.

Serratia causes fever and a drop in blood pressure that causes a lack of blood flow to organs; the bacteria can be transferred by touch.

The name and sex of the the baby, who weighed between 500 and 1,500 grams and died last weekend has not been released.

Although four other infants have tested positive for serratia they are not sick but have been isolated and are being closely monitored.

Tests are being conducted to determine if they all have the same strain.

Dr. McGeer says until the babies are clear of the bacteria, the level 3 neonatal unit will not accept any more infants.

Mothers experiencing high risk pregnancies will be transferred other hospitals.

Serratia causes fever and a drop in blood pressure that causes a lack of blood flow to organs; the bacteria can be transferred by touch.

The 30-year-old unit suffers from overcrowding making infection control more of a problem.

A new neonatal unit is planned with building due to start this month.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cystic fibrosis drug found to be safe and effective in newborns